Larger PLK1‐mutated CRC and lung cancer populations are also required to explore the interaction between PLK1 and KRAS mutations in CRC and compare the molecular features between PLK1‐mutated NSCLC and small cell lung cancer, respectively. This evidence concerns the gene PLK1 and non-small cell lung carcinoma.